Hims & Hers Health Inc. has come under fire after its Super Bowl advertisement promoting weight loss drugs has been deemed misleading by lawmakers and critics. The ad featured various clients touting their success with the company’s medications, calling them a ‘miracle’ for transforming their lives. Critics have pointed out that the ad failed to include crucial disclaimers regarding the potential side effects and health implications of the drugs being advertised. Senator Richard Blumenthal emphasized that the ad contributes to a harmful narrative, stating, “Misleading advertising during a high-profile event raises serious concerns about the distortion of reality for viewers, especially vulnerable audiences who may rely on such claims.” Following the ad’s airing, Hims saw a notable dip in its stock prices, dropping approximately 8% in after-hours trading. Lawmakers are now calling for the FDA to investigate the claims made in the advertisement. The backlash highlights the ongoing scrutiny surrounding direct-to-consumer advertising in the pharmaceutical industry, with many advocating for stricter regulations to ensure that consumers are fully informed about the products being marketed to them.
Hims & Hers Faces Backlash Over Misleading Super Bowl Ad for Weight Loss Drugs
